The Securities and Exchange Commission is set to grant or deny approval of the Winklevoss Bitcoin Trust ETF, an exchange-traded fund that would track the value of digital currency bitcoin. Coming nearly four years and a dozen amendments after the fund was first proposed, the ruling could come as early as March 10 and make gaining access to the currency as easy as logging into your online brokerage account.
QUIZ: Test Your Knowledge of ETFs
Bitcoin is a so-called cryptocurrency an encrypted digital currency created by computer programmers that can be exchanged electronically for goods and services. It serves as an alternative to traditional currencies, such as the U.S. dollar or the euro. For now, you can buy bitcoins on online exchanges, which often require an involved registration process and premium prices. Or you can mine them (create them), using extremely sophisticated computer codes. The value of a single bitcoin is determined by investor speculation. Worth almost nothing when it was created eight years ago, bitcoin hit a record high above $1,300 this week, topping the price of an ounce of gold. But the rise has been volatile, marked by steep dips that were triggered, in some cases, by high-profile hacks of online bitcoin exchanges.
Best Gold Stocks To Watch Right Now: Cumberland Pharmaceuticals Inc.(CPIX)
- [By Max Byerly]
COPYRIGHT VIOLATION NOTICE: “Cumberland Pharmaceuticals (CPIX) Research Coverage Started at B. Riley” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/3364464/cumberland-pharmaceuticals-cpix-research-coverage-started-at-b-riley.html.
Best Gold Stocks To Watch Right Now: Celyad SA(CYAD)
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering
- [By Lisa Levin]
Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis, Inc. (NASDAQ: ABAX) for $83 per share in cash.
Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
CELYAD SA/ADR (NASDAQ: CYAD) reported launch of 1.8 million share offering.
Verastem Inc (NASDAQ: VSTM) shares dropped 12 percent in pre-market trading after announcing a $35 million common stock offering.
- [By Lisa Levin] Gainers
Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
Best Gold Stocks To Watch Right Now: Tengasco, Inc.(TGC)
- [By Max Byerly]
Tigercoin (CURRENCY:TGC) traded 12.1% lower against the US dollar during the 1-day period ending at 23:00 PM E.T. on May 6th. One Tigercoin coin can now be bought for $0.0077 or 0.00000083 BTC on popular cryptocurrency exchanges. In the last week, Tigercoin has traded 6.4% lower against the US dollar. Tigercoin has a total market cap of $334,680.00 and approximately $64.00 worth of Tigercoin was traded on exchanges in the last 24 hours.
Best Gold Stocks To Watch Right Now: Corium International, Inc.(CORI)
- [By Motley Fool Staff]
Corium International (NASDAQ:CORI) Q2 2018 Earnings Conference CallMay. 14, 2018 5:00 p.m. ET
Prepared Remarks Questions and Answers Call Participants
Best Gold Stocks To Watch Right Now: Eli Lilly and Company(LLY)
- [By ]
AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”
Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
- [By ]
Cramer and the AAP team weigh in on Eli Lilly’s (LLY) deal to buy ARMO BioSciences (ARMO) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
- [By ]
Cramer and the AAP team say they’re trimming El Lilly (LLY) and adding WestRock (WRK) and Textron (TXT) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
- [By Lisa Levin] Companies Reporting Before The Bell
United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
PACCAR Inc (NASDAQ: PCAR) is projected to
- [By Keith Speights]
Eli Lilly (NYSE:LLY) and Incyte (NASDAQ:INCY) didn’t succeed on their first attempt last year to win approval for JAK inhibitor baricitinibin treating rheumatoid arthritis. The two companies regrouped to resubmit for approval of the drug but received mixed results in April from an FDA advisory committee, which recommended approval for a lower dose of baricitinib, but not the higher dose of the drug.